<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[62, 69] optimum duration of stenting after endopyelotomy.<br>[108, 111] symptom based questionnaire<br>[228, 231] drainage pattern.<br>[261, 278] incidence of urinary tract infections (11.5% versus 38.1%, p = 0.04).<br></td>
<td width=33%>
[62, 69] optimum duration of stenting after endopyelotomy.<br>[108, 111] symptom based questionnaire<br>[228, 231] drainage pattern.<br>[261, 278] incidence of urinary tract infections (11.5% versus 38.1%, p = 0.04).<br></td>
<td width=33%>
[62, 69] optimum duration of stenting after endopyelotomy.<br>[108, 111] symptom based questionnaire<br>[124, 140] diuretic scanning at 3, 6, 9 and 12 months and then yearly, and<br>[165, 176] age, sex, symptoms and ipsilateral glomerular filtration rate.<br>[227, 231] improved drainage pattern.<br>[238, 240] related symptoms<br>[257, 278] significant difference in the incidence of urinary tract infections (11.5% versus 38.1%, p = 0.04).<br>[310, 318] endopyelotomy and decrease stent related complications.

<br></td>
</tr>
